Skip to content

Sarah Cannon Outcomes Registry

Sarah Cannon Outcomes Registry

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02356822
Enrollment
0
Registered
2015-02-05
Start date
2014-12-31
Completion date
2024-12-31
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oncology

Brief summary

This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.

Detailed description

Q

Interventions

Oncology data registry

Sponsors

SCRI Development Innovations, LLC
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or older * Patients that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship. * Patient must have the ability to understand the nature of the trial and give written informed consent

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frame
quality improvement10 yrs
Treatment patterns and utilization5 yrs

Secondary

MeasureTime frame
Humanistic and economic outcomes10 yrs

Other

MeasureTime frame
safety and effectiveness10 yrs

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026